Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (NASDAQ: SKIN) generates a steady flow of news at the intersection of medical technology, professional aesthetics, and beauty. As the parent of Hydrafacial, SkinStylus, and Keravive, the company issues regular updates on financial performance, science-backed innovation, provider partnerships, and corporate governance, giving investors and industry followers insight into how its skin health platform is evolving.
On this page, readers can follow earnings announcements and financial results, where BeautyHealth reports net sales, gross margin, adjusted EBITDA, delivery systems sold, and active install base across the Americas, Asia-Pacific, and EMEA. These releases often include management commentary on trends in device sales versus consumables, the performance of the recurring revenue stream, and changes in regional go-to-market strategies.
News coverage also highlights product and innovation updates, such as the launch of boosters like HydraFillic with Pep9 and references to Hydralock HA Booster, as well as insights from the company’s Skintuition Report, which explores consumer trends in modern skin health and aesthetics. Additional stories focus on initiatives like the Hydrafacial Advisory Councils and Ambassador Network, which bring together plastic surgeons, dermatologists, aesthetic practitioners, and estheticians to guide product development, education, and clinical research.
Corporate and governance news includes executive appointments, board changes, and capital structure developments, such as the appointment of a new President and Chief Executive Officer, the addition of a new independent director, and updates related to convertible senior notes and charter amendments. For anyone tracking SKIN, this news feed offers a centralized view of the company’s operational progress, strategic priorities, and role in professional skin and scalp health.
The Beauty Health Company (NASDAQ:SKIN), owner of Hydrafacial™, has launched its Hydrafacial Advisory Councils and Ambassador Network, comprising leading plastic surgeons, dermatologists, aesthetic practitioners, and estheticians. The initiative aims to enhance product development, education, and clinical excellence.
Led by CEO Marla Beck, the program features inaugural council chairs including Ted Lain, MD, MBA, Blaklee Paige Smith, and Kelly Horton-Beeman. The councils will guide innovation, treatment protocols, and clinical research while supporting peer-to-peer learning initiatives. This strategic move builds upon Hydrafacial's existing provider support programs, including their HFX Training Programs which have trained over 60,000 providers globally.
BeautyHealth (NASDAQ: SKIN) reported Q2 2025 financial results, showing mixed performance with net sales of $78.2 million, down 13.7% year-over-year, but improved profitability metrics. The company achieved net income of $19.7 million, up from $0.2 million in Q2 2024, and Adjusted EBITDA of $13.9 million compared to $(5.2) million last year.
Key highlights include gross margin improvement to 62.8% (vs 45.2% in Q2 2024), successful debt restructuring, and an active install base of 35,193 units. The company raised its 2025 guidance, projecting net sales of $285-300 million and Adjusted EBITDA of $27-35 million. BeautyHealth also successfully launched HydraFillic with Pep9™ Booster and reported strong consumables performance, representing over 70% of revenue.
["Net income increased significantly to $19.7M from $0.2M YoY", "Gross margin improved to 62.8% from 45.2% YoY", "Adjusted EBITDA turned positive to $13.9M from $(5.2)M YoY", "Consumables now represent over 70% of revenue, showing recurring revenue strength", "Raised full-year 2025 guidance", "Successfully restructured debt obligations"]BeautyHealth (NASDAQ:SKIN), the company behind Hydrafacial™, has scheduled its second quarter 2025 financial results announcement for August 7, 2025, after market close. The company will host an investor conference call at 4:30 p.m. Eastern Time to discuss the results.
Investors can access the live webcast and supporting materials through BeautyHealth's investor relations website. A recording will be available approximately three hours after the call concludes.
BeautyHealth (NASDAQ: SKIN), the company behind Hydrafacial, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, after market close. The company will host an investor conference call at 4:30 p.m. Eastern Time following the results release.
Investors and interested parties can access:
- Live webcast of the call on BeautyHealth's investor relations website
- Supporting materials for the presentation
- Recording of the call (available approximately three hours after conclusion)
The company maintains transparency through various communication channels, including SEC filings, press releases, public conference calls, and their investor relations website, ensuring compliance with Regulation FD disclosure obligations.
BeautyHealth (NASDAQ: SKIN) reported Q4 2024 financial results, with net sales of $83.5 million, down 13.8% year-over-year, and full-year 2024 net sales of $334.3 million, declining 16.0% from 2023.
The company's active install base grew to 34,735 units from 31,446 in the prior year, driving growth in consumable sales. However, overall revenue decreased due to fewer unit placements, impacted by challenging macroeconomic conditions. Q4 gross margin improved to 62.7% from 47.2% in Q4 2023.
The company reported a Q4 net loss of $(10.3) million, relatively flat compared to $(9.4) million in Q4 2023. Adjusted EBITDA improved to $9.0 million from $3.4 million in Q4 2023, driven by lower operational spend and higher gross margins. Cash position stood at $370.1 million as of December 31, 2024.
BeautyHealth (NASDAQ: SKIN) has scheduled its fourth quarter and full year 2024 financial results announcement for March 12, 2025, after market close. The company, known for its flagship brand Hydrafacial, will host an investor conference call at 4:30 p.m. Eastern Time following the results release.
Interested parties can access the live webcast and supporting materials through BeautyHealth's investor relations website. A recording of the call will be made available approximately three hours after its conclusion.